Research
TINAG suppresses renal cell carcinoma progression and angiogenesis by rebalancing mTORC1 signaling via integrin α3β1 receptor
Nature ·
The Brief
- A study reports that TINAG suppresses renal cell carcinoma progression and angiogenesis.
- According to the study title, TINAG rebalances mTORC1 signalling via the integrin α3β1 receptor.
Why it matters
It describes a specific molecular pathway involved in renal cell carcinoma progression, which cancer researchers may use to guide further study of mTORC1 and integrin signalling.
Who’s affected
- cancer researchers
- oncology and nephrology specialists
- #renal cell carcinoma
- #tinag
- #mtorc1
- #angiogenesis
- #integrin